Nutrien vs Scotts Miracle-Gro
NTR and SMG side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NTR and SMG compare
Scotts Miracle-Gro grew revenue faster over the last twelve months (4.6% versus 3.5% for Nutrien).
Nutrien keeps more of each dollar of sales as profit, with a net margin of 8.4% compared with 2.1% at Scotts Miracle-Gro.
Scotts Miracle-Gro pays a dividend yielding 4.2%; Nutrien does not pay one.
Scotts Miracle-Gro scores higher on the StockData Score (12 against 9 for Nutrien), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NTR | SMG |
|---|---|---|
| Size and price | ||
| Market cap | – | $3.6B |
| Share price | $69.42 | $62.24 |
| Change, 1 year | 23.0% | 15.2% |
| Change, 5 years | 3.7% | −62.2% |
| Beta (5Y) | 0.47 | 1.33 |
| Employees | – | 5,200 |
| StockData Score | ||
| Total score | 9 | 12 (better) |
| Valuation score | 0 | 2 (better) |
| Growth score | 2 | 3 (better) |
| Performance score | 3 | 3 |
| Health score | 4 (better) | 1 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 51.4× |
| P/S | – | 1.0× |
| EV/EBITDA | – | 14.9× |
| P/FCF | – | 13.8× |
| FCF yield | – | 7.3% |
| Fair value | – | $48.43 |
| Margin of safety | – | −28.5% |
| Growth | ||
| Revenue growth (TTM) | 3.5% | 4.6% (better) |
| Revenue growth, 5Y average | 5.2% (better) | −3.7% |
| Net income growth (TTM) | 236% | – |
| EPS growth (TTM) | 243% | – |
| EPS growth, 5Y average | 41.9% (better) | −18.4% |
| Profitability | ||
| Gross margin | 31.0% | 31.8% (better) |
| Operating margin | 13.9% (better) | 11.0% |
| Net margin | 8.4% (better) | 2.1% |
| FCF margin | 7.9% (better) | 7.6% |
| Return on equity | 9.1% | – |
| Return on invested capital | 8.0% | 12.3% (better) |
| Financial health | ||
| Debt / equity | 0.42 | – |
| Net debt / EBITDA | 1.64 (better) | 5.45 |
| Interest coverage | 5.4× (better) | 3.4× |
| Current ratio | 1.34 (better) | 1.21 |
| Altman Z-score | – | 2.41 |
| Piotroski F-score | 8 (better) | 7 |
| Dividends and buybacks | ||
| Dividend yield | – | 4.2% |
| Payout ratio | 46.8% | 209% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | −18.5% |
| Buyback yield | – | 0.33% |
| Shareholder yield | – | 4.6% |
| Ownership | ||
| Held by institutions | 56.1% | 86.5% |
| Held by insiders | 0.00% | 53.3% |
| Insider net buying, 12 months | – | −$5.4M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 2.3% | 19.6% |
Go deeper
- NTR stock overview
- NTR income statement
- NTR valuation and score
- SMG stock overview
- SMG income statement
- SMG valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.